Clinical Trial Update: DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma

View source ↗

Summary

A completed clinical trial update examining DNA methylation biomarkers to predict survival after surgical resection in patients with lung adenocarcinoma, aiming…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Snippet

Sponsor: Nanjing University | Conditions: Lung Adenocarcinoma, Surgery | Status: COMPLETED